Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar [MSNBC.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MSNBC.com
Eli Lillyfourth-quarter earnings and revenueThe pharmaceutical giant anticipates its 2026 revenue will come in between $80 billion and $83 billion. Analysts expected revenue of $77.62 billion, according to LSEG.Lilly also expects adjusted earnings to be between $33.50 and $35 per share for the year. That compares with analysts' estimate of $33.23 per share, according to LSEG.The guidance comes in stark contrast to the outlook of rival Novo Nordisk, which is also grappling with lower prices in the U.S. following landmarkdeals both companies struck with President Donald Trumpsees sales and profit declining as much as 13% this yearMeanwhile, the midpoint of Lilly's revenue guidance sees sales growing by 25% this year.The strong outlook comes days after Lilly CEO Dave Ricks told CNBC inan exclusive interviewIn an earnings presentation Wednesday, Lilly cited several factors that it will benefit from this year, including Medicare coverage, continued worldwide demand for Mounjaro and Zepboun
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions [Yahoo! Finance]Yahoo! Finance
- Eil Lilly shares jump on strong GLP-1 sales, as Novo Nordisk tumbles [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 [CNBC]CNBC
- We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat [CNBC]CNBC
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website